February 7, 2025

Contribution of cuproptosis and immune-related genes to idiopathic pulmonary fibrosis disease – Frontiers

February 5, 2025

Neutral LPAR1 Antagonists for the Treatment of Idiopathic Pulmonary Fibrosis – ACS Publications

February 4, 2025

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis – Business Wire

January 30, 2025

Understanding Idiopathic Pulmonary Fibrosis: New Insights and Emerging Treatment Options – Frontiers

January 23, 2025

Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial – Nature